DCN Dx specializes in contract development of rapid point of care tests. We offer a variety of services and products that assist our clients in the design and development of user-centric, high performing diagnostic devices.
Contract development of rapid immunoassays is at the core of all that we do at DCN Dx. We focus on lateral flow, flow through, and microfuidic formats. Our staff has unparalleled experience in developing assays with tough specifications, regarding high sensitivity, quantification, multiplexing and reader integration. Our ISO 9001:2015 compliant development process allows for close integration of assay and device development pathways, which ensures the best chance of commercial success for the product.
As well as developing the assay itself, DCN Dx's integrated engineering team will design, develop and integrate your entire device. The engineers work closely with our scientists to create cassettes and sample handling devices that enhance the performance of your assay and meet all end-user specifications. We deliver the product, not just the parts.
DCN Dx also offers a variety of products and services to assist our clients at any stage of development, including:
- Custom, private education and training courses in lateral flow technology, during which we teach the details of how to develop and manufacture rapid assays.
- Consulting services to assist with any aspect of rapid assay development, manufacturing, regulation and commercialization.
- Custom protein-protein, protein-particle, small molecule-protein and small molecule- particle conjugations.
- Lateral flow material starter kits, conjugation kits, reagents, cassettes and materials for use during rapid assay development.
DCN Dx represents a single source that can help you manage and deliver completely validated assay platforms.